lithocholic acid has been researched along with Colorectal Neoplasms in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.25) | 18.7374 |
| 1990's | 5 (31.25) | 18.2507 |
| 2000's | 2 (12.50) | 29.6817 |
| 2010's | 5 (31.25) | 24.3611 |
| 2020's | 3 (18.75) | 2.80 |
| Authors | Studies |
|---|---|
| Jung, YD; Li, S; Lian, S; Nguyen, TT; Park, SY; Sah, DK; Ung, TT | 1 |
| Car, H; Gohal, S; Guzińska-Ustymowicz, K; Hryniewicka, A; Morzycki, JW; Pryczynicz, A; Sadowska, A; Sawicka, D; Sokołowska, E | 1 |
| Ahuja, N; Cai, Y; Gaule, P; Huang, H; Johnson, CH; Khan, SA; Lu, J; Lu, L; Muca, E; Paty, PB; Rattray, NJW; Rattray, Z; Shen, X; Theriot, CM; Yan, H; Zhang, Y | 1 |
| Do Jung, Y; Li, S; Lian, S; Nguyen, TT; Park, SY; Ung, TT; Xia, Y | 1 |
| Duan, X; Joshi, BP; Khondee, S; Owens, SR; Qiu, Z; Rabinsky, EF; Wang, TD; Zhao, L | 1 |
| Han, JY; Jung, YD; Lian, S; Nguyen, TT; Ung, TT; Xia, Y | 1 |
| Abe, T; Egawa, S; Fukase, K; Ii, T; Katayose, Y; Muto, M; Ohtsuka, H; Oikawa, M; Onogawa, T; Oshio, H; Rikiyama, T; Sato, T; Unno, M | 1 |
| Bartik, L; Egan, JB; Gerner, EW; Haussler, MR; Jacobs, ET; Jurutka, PW; Thompson, PA; Vitanov, MV | 1 |
| Befeler, AS; Eaton, JE; Harnois, D; Harrison, ME; Jorgensen, R; Kowdley, KV; Lindor, KD; Luketic, VA; McCashland, T; Pardi, DS; Petz, J; Silveira, MG; Sinakos, E | 1 |
| Brasitus, TA | 1 |
| Taguchi, F | 1 |
| Griffin, M; Haines, A; Hill, MJ; Meade, TW; Owen, RW; Thompson, MH; Wilkes, H; Williams, RE | 1 |
| Baker, PR; Barker, G; Davis, A; Donovan, IA; Hendrickse, CW; Imray, CH; Lawson, AM; Neoptolemos, JP; Radley, S | 1 |
| Hill, MJ | 1 |
| Campbell, GR; Cromie, AJ; Majury, CW; McKelvey, ST; Mills, JO; Mullan, FJ; Wilson, HK | 1 |
| Bilton, RF; Blakeborough, MH; Owen, RW | 1 |
1 review(s) available for lithocholic acid and Colorectal Neoplasms
| Article | Year |
|---|---|
The ratio of lithocholic to deoxycholic acid in faeces: a risk factor in colorectal carcinogenesis.
Topics: Biomarkers, Tumor; Colorectal Neoplasms; Deoxycholic Acid; Feces; Humans; Lithocholic Acid; Risk Factors | 1991 |
1 trial(s) available for lithocholic acid and Colorectal Neoplasms
| Article | Year |
|---|---|
High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis.
Topics: Adolescent; Adult; Aged; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis, Sclerosing; Colitis, Ulcerative; Colorectal Neoplasms; Female; Follow-Up Studies; Humans; Lithocholic Acid; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; Risk; Ursodeoxycholic Acid; Young Adult | 2011 |
14 other study(ies) available for lithocholic acid and Colorectal Neoplasms
| Article | Year |
|---|---|
Lithocholic Acid Induces miR21, Promoting PTEN Inhibition via STAT3 and ERK-1/2 Signaling in Colorectal Cancer Cells.
Topics: Cell Line, Tumor; Chenodeoxycholic Acid; Cholic Acid; Colorectal Neoplasms; Deoxycholic Acid; Detergents; HCT116 Cells; HT29 Cells; Humans; Lithocholic Acid; MAP Kinase Signaling System; MicroRNAs; Mitogen-Activated Protein Kinase 3; PTEN Phosphohydrolase; STAT3 Transcription Factor | 2021 |
Establishment of In Vitro and In Vivo Anticolorectal Cancer Efficacy of Lithocholic Acid-Based Imidazolium Salts.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Colorectal Neoplasms; Fluorouracil; Humans; Lithocholic Acid; Mice; Salts | 2022 |
Bile acid distributions, sex-specificity, and prognosis in colorectal cancer.
Topics: Bile Acids and Salts; Chenodeoxycholic Acid; Colonic Neoplasms; Colorectal Neoplasms; Female; Forkhead Transcription Factors; Glycochenodeoxycholic Acid; Humans; Lithocholic Acid; Male; Sex Distribution; Ursodeoxycholic Acid | 2022 |
Metformin inhibits lithocholic acid-induced interleukin 8 upregulation in colorectal cancer cells by suppressing ROS production and NF-kB activity.
Topics: Colorectal Neoplasms; HCT116 Cells; Humans; Interleukin-8; Lithocholic Acid; Metformin; NF-kappa B; Reactive Oxygen Species; Up-Regulation | 2019 |
Targeted therapy of colorectal neoplasia with rapamycin in peptide-labeled pegylated octadecyl lithocholate micelles.
Topics: Adenoma; Animals; Antibiotics, Antineoplastic; beta Catenin; Binding, Competitive; Cell Line, Tumor; Chemistry, Pharmaceutical; Colorectal Neoplasms; Drug Delivery Systems; Humans; Lithocholic Acid; Mice; Micelles; Peptides; Polyethylene Glycols; Sirolimus | 2015 |
Lithocholic Acid Stimulates IL-8 Expression in Human Colorectal Cancer Cells Via Activation of Erk1/2 MAPK and Suppression of STAT3 Activity.
Topics: Cell Line, Tumor; Colorectal Neoplasms; Enzyme Activation; Gene Expression Regulation, Neoplastic; Humans; Interleukin-8; Lithocholic Acid; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neoplasm Proteins; STAT3 Transcription Factor | 2017 |
Peroxisome proliferator-activated receptor alpha activates cyclooxygenase-2 gene transcription through bile acid transport in human colorectal cancer cell lines.
Topics: Adenoviridae; Bile Acids and Salts; Cell Line, Tumor; Colorectal Neoplasms; Cyclic AMP Response Element-Binding Protein; Cyclooxygenase 2; Electrophoretic Mobility Shift Assay; Gene Expression Regulation; Humans; Lithocholic Acid; Organic Anion Transporters, Sodium-Independent; PPAR alpha; Promoter Regions, Genetic; Solute Carrier Organic Anion Transporter Family Member 1B3; Transcription, Genetic; Transcriptional Activation; Transfection | 2008 |
Vitamin D receptor ligands, adenomatous polyposis coli, and the vitamin D receptor FokI polymorphism collectively modulate beta-catenin activity in colon cancer cells.
Topics: Adenomatous Polyposis Coli; beta Catenin; Caco-2 Cells; Calcitriol; Colorectal Neoplasms; Detergents; Gene Expression Regulation, Neoplastic; Humans; Intercellular Signaling Peptides and Proteins; Ligands; Lithocholic Acid; Polymorphism, Single Nucleotide; Receptors, Calcitriol; Signal Transduction; Transcription Factors; Transcription, Genetic; Wnt Proteins | 2010 |
Primary chemoprevention strategies for colorectal cancer: ursodeoxycholic acid and other agents.
Topics: Animals; Chemoprevention; Colon; Colorectal Neoplasms; Deoxycholic Acid; Humans; Lithocholic Acid; Rats; Sulfates; Ursodeoxycholic Acid | 1995 |
[Analysis of duodenal bile acids in patients with colorectal tumors and control subjects].
Topics: Adenoma; Aged; Bile Acids and Salts; Carcinoma; Chenodeoxycholic Acid; Colorectal Neoplasms; Deoxycholic Acid; Duodenum; Female; Humans; Intestinal Secretions; Lithocholic Acid; Male; Middle Aged | 1995 |
A prospective study of faecal bile acids and colorectal cancer.
Topics: Aged; Bile Acids and Salts; Colorectal Neoplasms; Deoxycholic Acid; Feces; Female; Functional Laterality; Humans; Lithocholic Acid; Male; Middle Aged; Prospective Studies | 2000 |
Faecal unconjugated bile acids in patients with colorectal cancer or polyps.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Bile Acids and Salts; Chenodeoxycholic Acid; Colorectal Neoplasms; Feces; Female; Humans; Intestinal Polyps; Lithocholic Acid; Male; Middle Aged | 1992 |
Bile acids and the increased risk of colorectal tumours after truncal vagotomy.
Topics: Bile Acids and Salts; Chenodeoxycholic Acid; Cholic Acids; Colorectal Neoplasms; Deoxycholic Acid; Female; Humans; Lithocholic Acid; Male; Middle Aged; Peptic Ulcer; Prospective Studies; Risk Factors; Vagotomy, Truncal | 1990 |
Free radical generating mechanisms in the colon: their role in the induction and promotion of colorectal cancer?
Topics: Colon; Colorectal Neoplasms; Deoxycholic Acid; Diet; Free Radicals; Humans; Lithocholic Acid; Oxidation-Reduction; Vitamin K | 1989 |